Search
Displaying results 1671 - 1680 of 10000 in total
3-isobutyl-1-methyl-7H-xanthine
go.drugbank.com/drugs/DB07954ExperimentalCategories: Heterocyclic Compounds, 2-RingSynonyms: 1-methyl-3-isobutylxanthine, 3-Isobutyl-1-methyxanthine3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE
go.drugbank.com/drugs/DB08093ExperimentalSynonyms: 3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE1-(biphenyl-4-ylmethyl)-1H-imidazole
go.drugbank.com/drugs/DB08369ExperimentalSynonyms: 1-(biphenyl-4-ylmethyl)-1H-imidazole(1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate
go.drugbank.com/drugs/DB08545ExperimentalSynonyms: (1S)-1-Phenylethyl (4-acetamidobenzyl)phosphonate1-(4-thiophen-2-ylphenyl)methanamine
go.drugbank.com/drugs/DB07259ExperimentalSynonyms: 1-(4-thiophen-2-ylphenyl)methanamine(2R)-2-ETHYL-1-HEXANESULFONIC ACID
go.drugbank.com/drugs/DB07518ExperimentalSynonyms: (2R)-2-ETHYL-1-HEXANESULFONIC ACIDRecombinant human palmitoyl protein thioesterase-1
go.drugbank.com/drugs/DB17980ExperimentalSynonyms: Recombinant human palmitoyl protein thioesterase-14,5,6,7-Tetrachloro-3h-Isobenzofuran-1-One
go.drugbank.com/drugs/DB03302ExperimentalSynonyms: 4,5,6,7-Tetrachloro-3h-Isobenzofuran-1-OneVandetanib
go.drugbank.com/drugs/DB05294ApprovedInvestigationalVandetanib is an oral once-daily kinase inhibitor of tumour angiogenesis and tumour cell proliferation with the potential for use in a broad range of tumour types. … On April 6 2011, vandetanib was approved by the FDA to treat nonresectable, locally advanced, or metastatic medullary thyroid cancer in adult patients.
Categories: Heterocyclic Compounds, 1-Ring, Cytochrome P-450 CYP3A4 Substrates with a Narrow Therapeutic IndexSynonyms: N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-4-quinazolinamine, N-(4-Bromo-2-fluorophenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amineRolitetracycline
go.drugbank.com/drugs/DB01301ApprovedWithdrawnA pyrrolidinylmethyl tetracycline.
Synonyms: N-(1-Pyrrolidinylmethyl)-tetracycline, N-(Pyrrolidinomethyl)tetracycline